Swiss National Bank
ONEM

Swiss National Bank’s 1Life Healthcare ONEM Stock Holding History

Swiss National Bank’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-330,900
Closed -$5.53M – 2699
2022
Q4 		$5.53M Buy
330,900
+8,800
+3% +$149K ﹤0.01% 1259
2022
Q3 		$5.52M Buy
322,100
+5,400
+2% +$84.8K ﹤0.01% 1219
2022
Q2 		$2.48M Sell
316,700
-44,400
-12% -$381K ﹤0.01% 1767
2022
Q1 		$4M Buy
361,100
+178,900
+98% +$2M ﹤0.01% 1584
2021
Q4 		$3.2M Hold
182,200
– – ﹤0.01% 1754
2021
Q3 		$3.69M Buy
182,200
+1,200
+0.7% +$30.8K ﹤0.01% 1677
2021
Q2 		$5.98M Buy
181,000
+59,400
+49% +$2.24M ﹤0.01% 1370
2021
Q1 		$4.75M Buy
121,600
+7,400
+6% +$347K ﹤0.01% 1492
2020
Q4 		$4.99M Buy
114,200
+57,000
+100% +$1.95M ﹤0.01% 1379
2020
Q3 		$1.62M Buy
57,200
+900
+2% +$28.4K ﹤0.01% 1819
2020
Q2 		$2.04M Buy
+56,300
New +$1.59M ﹤0.01% 1700

Swiss National Bank's ONEM Position: Q1 2023 in Review

Swiss National Bank sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 330,900 shares — an estimated $5.53M sold.

Swiss National Bank first reported a position in ONEM in Q2 2020 and held it in 11 quarters. The position peaked at $5.98M in Q2 2021. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Swiss National Bank reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Swiss National Bank sold 330,900 1Life Healthcare shares in Q1 2023, an estimated $5.53M.
  • Swiss National Bank first reported a position in 1Life Healthcare in Q2 2020 and held it in 11 quarters.
  • Swiss National Bank's 1Life Healthcare position peaked at $5.98M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Swiss National Bank's 13F filing for Q1 2023, filed 10 May 2023.